Evaluation of urinary nucleosides in breast cancer patients before and after tumor removal

Clinical Biochemistry

Volumn 42, Issue 6, 2009, Pages 540-543

  Cho, Sung Hee ^a,b   Choi, Man Ho ^a   Lee, Won Yong ^b   Chung, Bong Chul ^a  

^a Korea Institute of Science and Technology   (South Korea)

^b Yonsei University   (South Korea)

Author keywords

Breast cancer; DNA damage; Liquid chromatography mass spectrometry; Nucleosides

Indexed keywords

1 METHYLADENOSINE; 3 METHYLURIDINE; 5 HYDROXYMETHYLDEOXYURIDINE; 5 METHYL 2' DOEXYCYTIDINE; 8 HYDROXYDEOXYGUANOSINE; ADENOSINE; CYTIDINE; DEOXYGUANOSINE; GUANOSINE; N2 N2 DIMETHYGUANOSINE; NUCLEOSIDE; PSEUDOURIDINE; UNCLASSIFIED DRUG; URIDINE;

ADULT; ARTICLE; BREAST CANCER; CANCER PATIENT; CONTROLLED STUDY; EXTRACTION; FEMALE; HUMAN; LIQUID CHROMATOGRAPHY; MAJOR CLINICAL STUDY; METABOLITE; PATHOGENESIS; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; TANDEM MASS SPECTROMETRY; URINALYSIS;

ADENOSINE; ADULT; BREAST NEOPLASMS; CHROMATOGRAPHY, LIQUID; DEOXYGUANOSINE; FEMALE; GUANOSINE; HUMANS; MASTECTOMY; MIDDLE AGED; NUCLEOSIDES; OXIDATIVE STRESS; POSTOPERATIVE PERIOD; REACTIVE OXYGEN SPECIES; TANDEM MASS SPECTROMETRY; THYMIDINE;

EID: 61849178717     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2008.12.026     Document Type: Article

References (10)

1. Poulsen H.E., Prieme H., and Loft S. Role of oxidative DNA damage in cancer initiation and promotion. Eur. J. Cancer Prev. 7 (1998) 9-16
2. Rozenski J., Crain P.F., and McCloskey J.A. The RNA modification database: 1999 update. Nucleic Acids Res. 27 (1999) 196-197
3. Nakano K., Nakao T., Schram K.H., et al. Urinary excretion of modified nucleosides as biological marker of RNA turnover in patients with cancer and AIDS. Clin. Chim. Acta 218 (1993) 169-183
4. Seidel A., Brunner S., Sidel P., Fritz G.I., and Herbarth O. Modified nucleosides: an accurate tumour marker for clinical diagnosis of cancer, early detection and therapy control. Br. J. Cancer 94 (2006) 1726-1733
5. Cooke M.S., Olinski R., and Loft S. Measurement and meaning of oxidatively modified DNA lesions in urine. Cancer Epidemiol. Biomark. Prev. 17 (2008) 3-14
6. Kammerer B., Frickenscmidt A., Müller C.E., Laufer S., Gleiter C.H., and Liebich H. Mass spectrometric identification of modified urinary nucleosides used as potential biomedical markers by LC-ITMS coupling. Anal. Bioanal. Chem. 382 (2005) 1017-1026
7. Lee S.H., Jung B.H., Kim S.Y., and Chung B.C. A rapid and sensitive method for quantitation of nucleosides in human urine using liquid chromatography/mass spectrometry with direct urine injection. Rapid Commun. Mass Spectrom. 18 (2004) 973-977
8. Cho S.H., Jung B.H., Lee S.H., Lee W.Y., Kong G., and Chung B.C. Direct determination of nucleosides in the urine of patients with breast cancer using column-switching liquid chromatography-tandem mass spectrometry. Biomed. Chromatogr. 20 (2006) 1229-1236
9. Han X., and Liehr J.G. 8-Hydroxylation of guanine bases in kidney and liver DNA of hamsters treated with estradiol: role of free radicals in estrogen-induced carcinogenesis. Cancer Res. 54 (1994) 5515-5517
10. Park R.W., Holland J.F., and Jenkins R. Urinary purines in leukemia. Cancer Res. 22 (1962) 469-477